MTOR and neoplasm: Intriguingly, the suppression of mTOR activity is known to enhance the efficacy of dasatinib in other tumor types [34,35], and it may be worth investigating in the future whether this enhanced efficacy is the result of mTOR’s metabolic regulation or the metabolic changes are indicative of mTOR activity.